Evaluation of medical and health economic effectiveness of non-pharmacological secondary prevention of coronary heart disease
Falk Müller‐Riemenschneider(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Wolfgang Greiner(Bielefeld University), Angelina Bockelbrink(Charité - Universitätsmedizin Berlin), Charlotte Meinhard(University Medical Center), Kathrin Damm(Leibniz University Hannover), Christoph Vauth(Leibniz University of Applied Sciences), Stefan N. Willich(Brigham and Women's Hospital)
Cited by 6
Related Papers
Concurrent Morning Increase in Platelet Aggregability and the Risk of Myocardial Infarction and Sudden Cardiac Death
|New England Journal of Medicine|1987|1.1k
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618